Dissertação Final - Hospital Veterinário do Baixo Vouga

Referências bibliográficas
• Lana, SE. 2003. Chemotherapy in: BSAVA Manual of canine and feline oncology, 2 nd
edition; 86-103;
• Legendre AM. 2007. Treatment of Dogs with Lymphoma: A Work in Progress;
University of Tennessee, Editorial. J Vet Intern Med 21:1166–1167;
• Lowe AD. 2004. Alimentary lymphossarcoma in a 4-year-old Labrador retriever. Can
Vet J 45, 610–612;
• MacDonald VS, Thamm DH, Kurzman ID, Turek MM. and Vail DM. 2005. Does L-
Asparaginase Influence Efficacy or Toxicity When Added to a Standard CHOP Protocol
for Dogs with Lymphoma? J Vet Intern Med 19:732–736;
• Mackin AJ, Allen DG, Johnstone .B. 1995. Effects of vincristine and prednisone on
platelet numbers and function in clinically normal dogs. American Journal of Veterinary
Research 56, 100–108.
• Madewell BR, Feldman BF.1980. Characterization of anemias associated with neoplasia
in small animals. J Am Vet Med Assoc 176:419–425;
• Madewell BR. 1986. Hematologic and bone marrow cytological abnormalities in 75 dogs
with malignant lymphoma. J An Anita Hosp Assoc 22:235-240;
• McKnight JA. 2003. Principles of Chemotherapy. Clinical techniques in small Animal
Pratice. Elsevier Inc 18; Nº2; pp 67-72;
• Miller SC, Lloyd RD, Bruenger FW. 2003. Comparisons of the skeletal locations of
putative plutonium-induced osteossarcomas in humans with those in beagle dogs and
with naturally occurring tumors in both species. Radiat Res 160 (5): 517-523;
• Mischke R, Eberle N. 2009. Influence of a cyclic combination chemotherapeutic protocol
on primary haemostasis in dogs suffering from malignant lymphoma. The Vet Journal,
Hanover School of Veterinary Medicine, Germany;
• Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA, Frimberger
AE, L'Heureux DA. 2001. Evaluation of discontinuous treatment protocol (VELCAP-S)
for canine lymphoma. J Vet Intern Med 15:348-354;
• Moore PF, Olivry T and Naydant D. 1994. Animal Model, Canine Cutaneous
Epitheliotropic Lymphoma (Mycosis Fungoides) Is a Proliferative Disorder of CD8+ T
Cells; Amenican Society for Investigative Pathology. American Journal of Pathology
144, No. 2;
58